Quidel receives Emergency Authorization for rapid antigen combo diagnostic assay for influenza A+B and COVID-19
October 5, 2020 – Quidel Corporation (San Diego, CA), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, has received…